Stem cells injected into heart: a new hope for heart attack survivors?
NCT ID NCT05068674
First seen Sep 30, 2025 · Last updated May 01, 2026 · Updated 23 times
Summary
This early-phase study tests whether injecting lab-grown heart cells (from human embryonic stem cells) can safely improve heart function in people with long-term heart damage after a heart attack. About 18 adults aged 21-79 with chronic heart weakness will receive the cells via catheter. The main goal is to find the safest dose and see if the procedure is feasible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC ISCHEMIC LEFT VENTRICULAR DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford Hospital and Clinics
RECRUITINGPalo Alto, California, 94305, United States
Conditions
Explore the condition pages connected to this study.